REQUEST A DEMO
Total
USD $0.00
Search more companies

Orfeus Pharma OOD (Bulgaria)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Orfeus Pharma OOD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Orfeus Pharma OOD is an enterprise in Bulgaria, with the main office in Vidin. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on 2018. 1 (2023) employees currently work for Orfeus Pharma OOD. There was a net sales revenue increase of 38.32% reported in Orfeus Pharma OOD’s latest financial highlights for 2022. Over the same period, its total assets decreased by 96.89%. The net profit margin of Orfeus Pharma OOD decreased by 0.02% in 2022.

Headquarters
Ul. Ekzarh Yosif I 23 Vh. A Et. 2 Ap. 4
Vidin; Vidin; Postal Code: 3700

Contact Details: Purchase the Orfeus Pharma OOD report to view the information.

Basic Information
Total Employees:
Purchase the Orfeus Pharma OOD report to view the information.
Outstanding Shares:
Purchase the Orfeus Pharma OOD report to view the information.
Registered Capital:
Purchase the Orfeus Pharma OOD report to view the information.
Incorporation Date:
2018
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
47.62%
Purchase this report to view the information.
47.62%
Purchase this report to view the information.
4.76%
Company Performance
Financial values in the chart are available after Orfeus Pharma OOD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
38.32%
Total operating revenue
38.32%
Net Profit (Loss) for the Period
-33.33%
Total assets
-96.89%
Total equity
3.31%
Operating Profit Margin (ROS)
-0.04%
Net Profit Margin
-0.02%
Return on Equity (ROE)
0.77%
Quick Ratio
-0.59%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?